, Neubauer, A., Gevaert, P., Zidarn, M., Worm, M., Aberer, W., … Valenta, R. (2018). Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32. The Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2017.09.052 (Original work published 2018)